Conditions: Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Exocrine Pancreatic Cancer; Carcinoma, Squamous Cell of Head and Neck
Intervention: Drug: tisotumab vedotin
Sponsors: Seattle Genetics, Inc.; Genmab
Not yet recruiting
from #ORL via a.lsfakia on Inoreader https://ift.tt/2GLIXPI
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου